Accuray Invests $8M in RaySearch for Online Adaptive Therapy Push

Generated byAinvest NewsReviewed byThe Newsroom

Monday, Sep 14, 2026 4:14 pm ET1min read

ARAY--

Aime Summary

- AccurayARAY-- invests $8M in RaySearch to advance online adaptive radiation therapy integration.

- The partnership combines Accuray's imaging tech with RaySearch's planning solutions for therapy platforms.

- The deal supports Accuray's transformation, already yielding $20M+ cost/margin improvements in fiscal 2026.

- Success hinges on adoption rates and mitigating third-party dependency risks in the strategic initiative.

Accuray Inc. (ARAY) has partnered with RaySearch Laboratories in an extended alliance worth $8 million, accelerating its adoption of online adaptive radiation therapy. The collaboration integrates Accuray's imaging technology and radiation therapy platforms with RaySearch's planning and workflow solutions. The deal supports Accuray's transformation plan, which has already delivered cost and margin improvements of over $20 million in fiscal 2026. However, adoption risk and third-party dependency are key considerations for the success of this strategic initiative.

Ainvest News

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue